1. Home
  2. MAIA vs OPTX Comparison

MAIA vs OPTX Comparison

Compare MAIA & OPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MAIA
  • OPTX
  • Stock Information
  • Founded
  • MAIA 2018
  • OPTX 1981
  • Country
  • MAIA United States
  • OPTX United States
  • Employees
  • MAIA N/A
  • OPTX N/A
  • Industry
  • MAIA Biotechnology: Pharmaceutical Preparations
  • OPTX Blank Checks
  • Sector
  • MAIA Health Care
  • OPTX Finance
  • Exchange
  • MAIA Nasdaq
  • OPTX Nasdaq
  • Market Cap
  • MAIA 52.8M
  • OPTX 51.9M
  • IPO Year
  • MAIA 2022
  • OPTX N/A
  • Fundamental
  • Price
  • MAIA $2.00
  • OPTX $1.92
  • Analyst Decision
  • MAIA
  • OPTX
  • Analyst Count
  • MAIA 0
  • OPTX 0
  • Target Price
  • MAIA N/A
  • OPTX N/A
  • AVG Volume (30 Days)
  • MAIA 346.7K
  • OPTX 3.0M
  • Earning Date
  • MAIA 11-12-2024
  • OPTX 11-14-2024
  • Dividend Yield
  • MAIA N/A
  • OPTX N/A
  • EPS Growth
  • MAIA N/A
  • OPTX N/A
  • EPS
  • MAIA N/A
  • OPTX 0.00
  • Revenue
  • MAIA N/A
  • OPTX $29,392,186.00
  • Revenue This Year
  • MAIA N/A
  • OPTX N/A
  • Revenue Next Year
  • MAIA N/A
  • OPTX N/A
  • P/E Ratio
  • MAIA N/A
  • OPTX $1,153.32
  • Revenue Growth
  • MAIA N/A
  • OPTX 4.36
  • 52 Week Low
  • MAIA $1.17
  • OPTX $0.85
  • 52 Week High
  • MAIA $5.99
  • OPTX $8.39
  • Technical
  • Relative Strength Index (RSI)
  • MAIA 44.72
  • OPTX 45.33
  • Support Level
  • MAIA $1.97
  • OPTX $2.18
  • Resistance Level
  • MAIA $2.44
  • OPTX $2.43
  • Average True Range (ATR)
  • MAIA 0.20
  • OPTX 0.56
  • MACD
  • MAIA 0.00
  • OPTX -0.17
  • Stochastic Oscillator
  • MAIA 8.33
  • OPTX 3.36

About MAIA MAIA Biotechnology Inc.

MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company. The company develops targeted immunotherapies for cancer. The company is an immune-oncology company, focused on the development of first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. The company's program is THIO, a potential cancer telomere-targeting agent in clinical development for the treatment of telomerase-positive cancer cells.

About OPTX Syntec Optics Holdings Inc.

Syntec Optics Holdings Inc is vertically integrated from design and component manufacturing for lens system assembly to imaging module integration for system solutions. Making its tools, molding, and nano machining allows close interaction and recut ability, enabling special techniques to hold tolerances to sub-micron levels. It has steadily developed a variety of other complementary manufacturing techniques to provide a wide suite of horizontal capabilities including thin film deposition coatings, glass molding, polymer molding, tool-making, mechanical manufacturing, and nano machining.

Share on Social Networks: